Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Skinvisible (SKVI) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Skinvisible (SKVI) over the last 17 years, with Q3 2025 value amounting to 0.13%.

  • Skinvisible's Return on Capital Employed rose 100.0% to 0.13% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.13%, marking a year-over-year increase of 100.0%. This contributed to the annual value of 0.17% for FY2024, which is 200.0% up from last year.
  • As of Q3 2025, Skinvisible's Return on Capital Employed stood at 0.13%, which was up 100.0% from 0.14% recorded in Q2 2025.
  • Over the past 5 years, Skinvisible's Return on Capital Employed peaked at 0.17% during Q2 2023, and registered a low of 0.08% during Q1 2022.
  • For the 5-year period, Skinvisible's Return on Capital Employed averaged around 0.08%, with its median value being 0.12% (2024).
  • Its Return on Capital Employed has fluctuated over the past 5 years, first plummeted by -1800bps in 2021, then soared by 2200bps in 2023.
  • Skinvisible's Return on Capital Employed (Quarter) stood at 0.07% in 2021, then soared by 206bps to 0.07% in 2022, then surged by 108bps to 0.15% in 2023, then rose by 15bps to 0.17% in 2024, then dropped by -25bps to 0.13% in 2025.
  • Its Return on Capital Employed was 0.13% in Q3 2025, compared to 0.14% in Q2 2025 and 0.15% in Q1 2025.